Dan Jones. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useBevacizumabCarcinoma, Non-Small-Cell Lung/drug therapyClinical Trials as TopicDrug Therapy, CombinationErlotinib HydrochlorideHumansNeoplasms/drug therapyQuinazolines/adverse effectsQuinazolines/therapeutic use
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsQuinazolinesBevacizumabErlotinib Hydrochloride
Year: 2009 PMID: 19204674 DOI: 10.1038/nbt0209-108
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908